Impact System® Kit Plasma Detoxification Treatment Is For Patients With Sepsis, Liver Failure And Drug Overdose

“The most important innovation of this technology is the ability to manage (reduce) cytokine cascade storm (“hypercytokinemia”), and thus prevent the devastating sequelae of further organ compromise and failure. Any clinically significant improvements and patient benefits will only come from those technologies, such as the I.M.P.A.C.T SYSTEM® KIT, that can effectively and efficiently decrease cytokine burden.

As more physicians and hospitals become comfortable with the I.M.P.A.C.T SYSTEM® KIT safety profile and results, the opportunity to move this treatment earlier in the patients’ clinical course, should enhance patient outcomes, further reducing morbidity and mortality. The possibility to intervene in the treatment of graft versus host disease (GVHD), acute pancreatitis, acute respiratory distress syndrome (ARDS), avian influenza, and systemic inflammatory response syndrome (SIRS) remain applications to be explored.”

Patrick Maguire, MD, PhD, MBA, Chief Medical Officer and Board member, HemoLife Medical, Inc.